To verify Rnaseh2c’s role as a bona fide metastasis modifier, we knocked down Rnaseh2c in a second mouse metastatic mammary cancer cell line, 4T1 (S3A and S3B Fig). This evidence concerns the gene RNASEH2C and breast cancer.